Release date: 2026-10-21 13:48:56 Recommended: 2
Pazopanib (LUCiPazo) is indicated for adult patients with advanced renal cell carcinoma (RCC) and adult patients with advanced soft tissue sarcoma (STS) who have previously received chemotherapy.